Letter to the Editor

Pharmacology and Toxicology

Volumn 90, Issue 1, 2002, Pages 4-

  Håkanson, Rolf ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM; PLACEBO; ANTIDEPRESSANT AGENT;

CLINICAL RESEARCH; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; HUMAN; LETTER; METHODOLOGY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLICATION; SCIENTIFIC LITERATURE; SUICIDAL BEHAVIOR; CLINICAL TRIAL; STEREOISOMERISM;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS; STEREOISOMERISM;

EID: 0036370902     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.t01-1-900102.x     Document Type: Letter

References (4)

1. Sponsorship, authorship and accountability
2. Escitalopram (S-enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model
3. Letter to the Editor
4. Recommendations guiding physicians in biomedical research involving human subjects